ArticleThe World Allergy Organization journal2018
Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study.
Abstract read
In one paragraph
Article in The World Allergy Organization journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Comparison of Allergic Rhinitis Treatments on Utilities and Quality of Life: A MASK-air Study.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026Observational
- ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases.Clinical and translational allergy · 2026Article
- Factors that influence user adherence of the Mask-air® application.Clinical and translational allergy · 2025Article
- An Assessment of Perspectives and Concerns Among Research Participants of Childbearing Age Regarding the Health-Relatedness of Data, Online Data Privacy, and Donating Data to Researchers: Survey Study.Journal of medical Internet research · 2023Article
- The efficacy of a novel smart watch on medicine adherence and symptom control of allergic rhinitis patients: Pilot study.The World Allergy Organization journal · 2023Article
- Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-airClinical and translational allergy · 2023Article
- Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities.Clinical and translational allergy · 2022Article
- Mobile health app for monitoring allergic rhinitis and asthma in real life in Lithuanian MASK-air users.Clinical and translational allergy · 2022Article
- Dynamically adjusting case reporting policy to maximize privacy and public health utility in the face of a pandemic.Journal of the American Medical Informatics Association : JAMIA · 2022Article
- Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®.Clinical and translational allergy · 2021Review
- Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report.Journal of thoracic disease · 2021Article
- Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study.Clinical and translational allergy · 2020Review
- Spatial performance of location-based alerts in France.International journal of disaster risk reduction : IJDRR · 2020Article
- Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing.Allergy, asthma & immunology research · 2020Review
- Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.Clinical and translational allergy · 2019Review
- Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.Clinical and translational allergy · 2019Review
- How the Smartphone Is Changing Allergy Diagnostics.Current allergy and asthma reports · 2018Review
- MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence.Clinical and translational allergy · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
77 authors.
D SamrethKyomed, Montpellier, France.
S ArnavielheKyomed, Montpellier, France.
F IngenriethSelbstregulierung Informationswirtschaft eV, Berlin, Germany.
A BedbrookMACVIA-France, Fondation partenariale FMC VIA-LR, Montpellier, France.
G L OnoratoMACVIA-France, Fondation partenariale FMC VIA-LR, Montpellier, France.
R MurrayMedScript Ltd, Dundalk, Co Louth, Ireland.
R Almeida5Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto; and Medina, Lda, Porto, Portugal.
M A Mizani6Asthma UK Centre for Applied Research, Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
J Fonseca5Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto; and Medina, Lda, Porto, Portugal.
E Costa7UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal.
J Malva8Institute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, Ageing@Coimbra EIP-AHA Reference Site, University of Coimbra, Coimbra, Portugal.
M Morais-AlmeidaAllergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
A M Pereira10Allergy Unit, CUF-Porto Hospital and Institute; Center for Research in Health Technologies and information systems CINTESIS, Universidade do Porto, Porto, Portugal.
A Todo-Bom11Imunoalergologia Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
E Menditto12CIRFF, Federico II University, Naples, Italy.
C Stellato13Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
M T Ventura14Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
D Larenas-Linnemann15Center of Excellence in Asthma and Allergy, Hospital Médica Sur, México City, Mexico.
J-M Fuentes-PérezMexico City, Mexico.
Y R Huerta-VillalobosMexico City, Mexico.
A A Cruz17ProAR - Nucleo de Excelencia em Asma, Brasil and WHO GARD Planning Group, Federal University of Bahia, Salvador, Brazil.
R Stelmach18Pulmonary Division, Heart Institute (InCor), Hospital da Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil.
J da Silva19Department of Internal Medicine and Allergy Clinic of Professor Polydoro Ernani de São Thiago University Hospital, Federal University of Santa Catarina (UFSC), Florianopolis, SC Brazil.
R Emuzyte20Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
V Kvedariene21Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
A Valiulis22Clinic of Children's Diseases, and Institute of Health Sciences, Department of Public Health, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania.
I Annesi-Maesano24Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, Medical School Saint Antoine, INSERM and Sorbonne Université, Paris, France.
I BosseAllergist, La Rochelle, France.
P Demoly26Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
P Devillier27UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
J F FontaineAllergist, Reims, France.
P Kuna29Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
B Samolinski30Samolinski. Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
L KlimekCenter for Rhinology and Allergology, Wiesbaden, Germany.
R Mösges32Institute of Medical Statistics, and Computational Biology, Medical Faculty, University of Cologne, Cologne, Germany.
O PfaarCenter for Rhinology and Allergology, Wiesbaden, Germany.
S Shamai32Institute of Medical Statistics, and Computational Biology, Medical Faculty, University of Cologne, Cologne, Germany.
M BewickiQ4U Consultants Ltd, London, UK.
D RyanWoodbrook Medical Centre, Loughborough, UK.
A Sheikh6Asthma UK Centre for Applied Research, Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
J M AntoISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
V Cardona42S Allergologia, S Medicina Interna, Hospital Vall d'Hebron, Barcelona, Spain.
J Mullol43Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic; Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
A Valero44Pneumology and Allergy Department CIBERES and Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, University of Barcelona, Barcelona, Spain.
N H Chavannes45Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
W J Fokkens46Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, the Netherlands.
S Reitsma46Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, the Netherlands.
R E Roller-Wirnsberger47Department of Internal Medicine, Medical University of Graz, Graz, Austria.
P V Tomazic48Department of ENT, Medical University of Graz, Graz, Austria.
T Haahtela49Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
S Toppila-Salmi49Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
E Valovirta50Department of Lung Diseases and Clinical Immunology, University of Turku and Terveystalo allergy clinic, Turku, Finland.
M Makris51Division of Infection, Immunity 1 Respiratory Medicine, University of Manchester, Manchester, UK.
N G Papadopoulos51Division of Infection, Immunity 1 Respiratory Medicine, University of Manchester, Manchester, UK.
E P Prokopakis53Department of Otorhinolaryngology University of Crete School of Medicine, Heraklion, Greece.
F PsarrosAllergy Department Athens Naval Hospital, Athens, Greece.
B Gemicioğlu55Department of Pulmonary Diseases, Istanbul University, Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
A Yorgancioglu56Department of Pulmonary Diseases, Faculty of Medicine, Turkey and GARD Executive Committee, Celal Bayar University, Manisa, Turkey.
C Bindslev-Jensen57Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark.
E Eller57Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark.
I Kull58Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
M Wickman59Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden.
C Bachert60Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
P W Hellings61Department of Otorhinolaryngology, Univ Hospitals Leuven, Leuven, Belgium.
B PuginEuforea, Brussels, Belgium.
S Bosnic-AnticevichWoolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW Australia.
R E O'Hehir65Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria Australia.
V Kolek67Department of Respiratory Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
M Sova67Department of Respiratory Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
K Wehner68Fachbereich Biologie, Technische Universität, Darmstadt, Germany.
G De VriesPeercode BV, Geldermalsen, The Netherlands.
M van EerdPeercode BV, Geldermalsen, The Netherlands.
D LauneKyomed, Montpellier, France.
J WittmannSelbstregulierung Informationswirtschaft eV, Berlin, Germany.
J BousquetEuforea, Brussels, Belgium.
P Poncelet72LIRMM, Montpellier, France.
MASK study group
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCollecting data on the localization of users is a key issue for the MASK (Mobile Airways Sentinel networK: the Allergy Diary) App. Data anonymization is a method of sanitization for privacy. The European Commission's Article 29 Working Party stated that geolocation information is personal data.To assess geolocation using the MASK method and to compare two anonymization methods in the MASK database to find an optimal privacy method.
methodsGeolocation was studied for all people who used the Allergy Diary App from December 2015 to November 2017 and who reported medical outcomes. Two different anonymization methods have been evaluated: Noise addition (randomization) and k-anonymity (generalization).
resultsNinety-three thousand one hundred and sixteen days of VAS were collected from 8535 users and 54,500 (58.5%) were geolocalized, corresponding to 5428 users. Noise addition was found to be less accurate than k-anonymity using MASK data to protect the users' life privacy. DISCUSSION: k-anonymity is an acceptable method for the anonymization of MASK data and results can be used for other databases.
Indexed as
AnonymizationAppAsthmaMASKRhinitis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.